In summary, we provide evidence that a combination of the V1-deleted envelope virus-like particle delivered with the DNA/ALVAC/gp120/alum vaccine platform, and SAMT-247 is highly efficacious in preventing vaginal infection by a neutralization-resistant, highly pathogenic virus. This evidence concerns the gene ITIH4 and infective vaginitis.